Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

High-Throughput Nucleotide Sequencing × Lymphoid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 7 Thoracic 4 Breast 3 Sarcoma 2 Gynecologic 2 Genitourinary 2 Tumor-Agnostic 1 Plasma cell 1 Other solid neoplasm 1 Other hematologic neoplasm 1 Myeloid 1 Lymphoid 1 Head & Neck 1 CNS 1

Conditions

Neoplasm, Residual 1 Lymphoma, Non-Hodgkin 1

Interventions

Rituximab 1179 Cyclophosphamide 1106 Vincristine 558 Doxorubicin 499 Etoposide 448 Prednisone 424 Cytarabine 405 fludarabine 400 Methotrexate 361 Dexamethasone 339 fludarabine phosphate 328 Lenalidomide 304 Filgrastim 295 Bendamustine Hydrochloride 235 Radiotherapy 231 venetoclax 222 ibrutinib 214 obinutuzumab 201 Melphalan 191 Peripheral Blood Stem Cell Transplantation 190 Granulocyte Colony-Stimulating Factor 174 Gemcitabine 169 Bortezomib 165 Busulfan 158 Whole-Body Irradiation 155 Mycophenolic Acid 145 Tacrolimus 125 Magnetic Resonance Spectroscopy 123 pegaspargase 122 Specimen Handling 121

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02339805 2017-07-07

LymphoSeq

Centre Henri Becquerel

Phase NA Completed

Lymphoma, Non-Hodgkin, Neoplasm, Residual

Data powered by HemOnc (CC BY 4.0) Colophon ⚡